Author

Katherine M McGrath

Observed names: K M McGrath, K McGrath, K. M Mcgrath, K. M. McGRATH, K. M. McGrath, K. M. Mcgrath, K. McGrath, K.M. McGRATH, K.M. McGrath, Katherine M Mcgrath, Katherine M. McGRATH, Katherine M. McGrath, Katherine M. Mcgrath, Katherine McGrath

Observed institutions: University of North Carolina at Chapel Hill, Atrium Health Wake Forest Baptist, University of Vienna, The Royal Melbourne Hospital, The University of Melbourne, Walter and Eliza Hall Institute of Medical Research, Hebrew University of Jerusalem, Austin Hospital, Government of Victoria, The Alfred Hospital, Yale University, Hunter New England Local Health District, Austin Health, Sheffield Children's Hospital, Wake Forest University, University of Newcastle Australia, University of Sheffield

OpenAlex ID: A5111930922

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

1992 · W.P. Sheridan, R.M. Fox, et al. · The Lancet · 857

Patient journeys: the process of clinical redesign

2008 · David I Ben‐Tovim, Melissa L Dougherty, et al. · The Medical Journal of Australia · 155

Reversal of aortic stenosis, bleeding gastrointestinal angiodysplasia, and von Willebrand syndrome by aortic valve replacement

1996 · RobertP. Anderson, Katherine McGrath, et al. · The Lancet · 89

The Significance of Subnormal Serum Vitamin B 12 Concentration in Older People: A Case Control Study

1996 · J. Metz, A.H. Bell, et al. · Journal of the American Geriatrics Society · 88

Appropriateness of transfusions of red cells, platelets and fresh frozen plasma

1995 · Jack Metz, Katherine M McGrath, et al. · The Medical Journal of Australia · 70

Biochemical indices of vitamin B12 nutrition in pregnant patients with subnormal serum vitamin B12 levels

1995 · Jack Metz, Katherine McGrath, et al. · American Journal of Hematology · 70

Thrombin Stimulates Expression of Tissue-Type Plasminogen Activator and Plasminogen Activator lnhibitor Type 1 in Cultured Human Vascular Smooth Muscle Cells

1993 · Johann Wojta, Marisa Gallicchio, et al. · Thrombosis and Haemostasis · 67

Implementing and sustaining transformational change in health care: lessons learnt about clinical process redesign

2008 · Katherine M McGrath, Denise M Bennett, et al. · The Medical Journal of Australia · 57

Analysis of cerbB2 expression using a panel of 6 commercially available antibodies

1994 · Inny Busmanis, Frank Feleppa, et al. · Pathology · 51

Maternal immunization to Gov system alloantigens on human platelets

1997 · José O. Bordin, John G. Kelton, et al. · Transfusion · 49

Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells

1994 · J Wojta, T Nakamura, et al. · Blood · 44

PDF

Characterization of a Variant Prothrombin in a Patient Congenitally Deficient in Factors II, VII, IX and X

1980 · C. A. Johnson, K. S. Chung, et al. · British Journal of Haematology · 38

Macrophage colony-stimulating factor and granulocyte-macrophage colony- stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes

1993 · JA Hamilton, GA Whitty, et al. · Blood · 37

PDF

Regulation of Plasminogen Activator Inhibitor-1 Levels in Human Monocytes

1993 · John A. Hamilton, Genevieve A. Whitty, et al. · Cellular Immunology · 34

Production of tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) by murine pre-B and B cell lymphomas.

1990 · R Laskov, G Lancz, et al. · The Journal of Immunology · 34

Health services under siege: the case for clinical process redesign

2008 · Tony J O’Connell, David I Ben‐Tovim, et al. · The Medical Journal of Australia · 33

Cytokine Regulation of the Synthesis of Plasminogen Activator Inhibitor-2 by Human Vascular Endothelial Cells

1993 · Hans Zoellner, Johann Wojta, et al. · Thrombosis and Haemostasis · 33

Human albumin solutions: consensus statements for use in selected clinical situations

1992 · Martin B Van Der Weyden, Fedora R Trinker, et al. · The Medical Journal of Australia · 29

Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells.

1994 · M Gallicchio, S Argyriou, et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 28

Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts

1992 · John A. Hamilton, Daisy Cheung, et al. · Arthritis & Rheumatism · 28

Marrow proliferation and the appearance of giant neutrophils in response to recombinant human granulocyte colony stimulating factor (rhG‐CSF)

1992 · L. J. Campbell, D. W. Maker, et al. · British Journal of Haematology · 28

Liver disease complicating severe haemophilia in childhood.

1980 · K M McGrath, J S Lilleyman, et al. · Archives of Disease in Childhood · 28

PDF

Thrombocytopenia in two patients treated with low-dose heparin.

1978 · P C Galle, H B Muss, et al. · PubMed · 28

Clinical process redesign for unplanned arrivals in hospitals

2008 · Tony J O’Connell, Jane E Bassham, et al. · The Medical Journal of Australia · 27

γ-Interferon counteracts interleukin-1α stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro

1992 · Johann Wojta, Hans Zoellner, et al. · Biochemical and Biophysical Research Communications · 27

Works count: 70

Citation count: 2,455

H-index: 26

I10-index: 45